Caroline McGregor

Title: The Innovative Journey of Caroline McGregor

Introduction

Caroline McGregor is a notable inventor based in Cranford, NJ (US). She has made significant contributions to the field of pharmaceuticals through her innovative work on polymeric nanoparticles. Her research focuses on developing advanced methods for creating and utilizing these nanoparticles, which have potential applications in drug delivery and other medical fields.

Latest Patents

Caroline McGregor holds one patent titled "Polymeric nanoparticles and methods of making and using same." This patent describes polymeric nanoparticles that comprise 8-[4-(1-aminocyclobutyl)phenyl]-9-phenyl-2H-[1,2,4]-triazolo-[3,4-fJ[1,6]-naphthyridin-3-one (Compound A), or a pharmaceutically acceptable salt thereof. The nanoparticles consist of about 50 to about 99.8 weight percent of a diblock poly(lactic) acid-poly(ethylene)glycol copolymer or a diblock poly(lactic acid-co-glycolic acid)-poly(ethylene)glycol copolymer. The total amount of poly(ethylene)glycol in the nanoparticle is about 10 to about 30 weight percent, along with about 0.2 to about 30 weight percent of Compound A.

Career Highlights

Throughout her career, Caroline has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme Corporation and Pfizer Corporation. Her experience in these organizations has allowed her to develop her expertise in the field of drug formulation and delivery systems.

Collaborations

Caroline has collaborated with talented individuals such as Young Ho Song and Greg Troiano. These partnerships have contributed to her innovative research and the successful development of her patented technologies.

Conclusion

Caroline McGregor's work in the field of polymeric nanoparticles showcases her dedication to advancing pharmaceutical science. Her innovative contributions have the potential to impact drug delivery systems significantly.